Lessons Learned from the COVID-19 Pandemic: The Intranasal Administration as a route for treatment - A Patent Review
{{output}}
The COVID-19 pandemic exposed the fragility of today's marketed treatments for respiratory infections. As a primary site of infection, the upper airways may represent a key access route for the control and treatment for these conditions. The present study aim... ...
